Alexion and Complement Pharma Announce Partnership to Co-Develop Pre-Clinical Complement Inhibitor for Neurodegenerative Disorders Collaboration provides opportunity to expand on Alexion’s two decades ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results